0.0350USD+11.82%Mkt Cap: —P/E: —Last update: 2026-06-01
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United Sta…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit-9.74M USD
Net Income (TTM)-22.45M USD
Revenue/Share—
Last Price0.0350 USD
Fiscal Year End—
MR Quarter—
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.02
EPS (TTM)-1.73
EPS (Forward)—
52W Range
0.016143% of range0.0601
52W High0.0601 USD
52W Low0.0161 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-894.81%
ROA-148.94%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.25M USD
CapEx (TTM)162.14K USD
FCF Margin—
FCF Yield—
Net Debt-18.46M USD
Net Debt/EBITDA0.78
Balance Sheet
Debt/Equity3.50
Current Ratio2.55
Quick Ratio2.37
Book Value/Sh1.584 USD
Cash/Share1.950 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float12.94M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta-0.81
S&P 52W Chg27.94%
Avg Vol (30d)11.20K
Avg Vol (10d)—
Technical Indicators
RSI (14)27.3
MACD-0.0069
MACD Signal-0.0031
MACD Hist.-0.0038
BB Upper0.0812 USD
BB Middle0.0534 USD
BB Lower0.0257 USD
BB Width103.74%
ATR (14)0.0052 USD
Vol Ratio (20d)5.71x